Brenntag (XTRA:BNR) just reported third quarter 2026 results, with sales of €4,263 million and net income of €129 million, catching investor attention ahead of any longer term conclusions.
The share price reaction has been mixed. Brenntag’s stock is up 18.29% on a year to date share price return, although the 30 day share price return is down 9.81% and the 3 year total shareholder return is down 14.94%. This suggests that recent momentum is still rebuilding after a weaker multi year stretch.
Scan Brenntag’s peers that combine rising earnings with balance sheet support using our curated list of list of solid balance sheet and fundamentals (199 results) for ideas beyond this single stock.
Brenntag now trades only slightly below the average analyst target, while some models still flag a large intrinsic discount. Is the market rightly cautious after that recent pullback, or is it mispricing the improved earnings base?
Brenntag’s last close of €58.66 sits slightly above the analyst consensus Narrative fair value of €57.73, which uses a 7.04% discount rate to weigh its long term cash generation and earnings profile. That analyst consensus Narrative on Simply Wall St leans heavily on cost savings, trade flows and modest revenue expansion to frame where the current share price sits.
Ongoing structural cost-out and organizational simplification through 2027, including the targeted additional €200m to €250m of savings on top of the €165m already delivered and supported by over 800 headcount reductions, could lift Brenntag’s net margins and earnings as these savings increasingly flow through the income statement.
See why 25 investors see Brenntag as 2% overvalued.
Result: Fair Value of €57.73 (OVERVALUED)
Still, if Chinese export pressure keeps pricing weak or staff costs eat into Brenntag’s planned savings, that fair value anchor could quickly look fragile.
Find out about the key risks to this Brenntag narrative.
The analyst narrative pegs Brenntag as 1.6% overvalued at €57.73, yet our DCF model points in the opposite direction. On that framework, the shares at €58.66 sit about 34.5% below an estimated future cash flow value of €89.50. Which yardstick do you lean on when the gap is this wide?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Brenntag for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 201 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Unsure whether Brenntag’s mixed signals really add up? Review the full breakdown now and consider the 3 key rewards and 1 important warning sign.
If Brenntag has you thinking harder about where to put fresh capital, do not stop here. Use Simply Wall St screeners to compare different types of opportunities side by side.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com